Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine

S. Jonsson; G. Vidarsson; H. Valdimarsson; G. Schiffman; R. Schneerson; I. Jonsdottir

doi:10.1183/09031936.02.00289702

Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine

European Respiratory Journal ◽

10.1183/09031936.02.00289702 ◽

2002 ◽

Vol 20 (4) ◽

pp. 813-818 ◽

Cited By ~ 13

Author(s):

S. Jonsson ◽

G. Vidarsson ◽

H. Valdimarsson ◽

G. Schiffman ◽

R. Schneerson ◽

...

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Copd Patients ◽

Pneumococcus Type

Download Full-text

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Other Paediatric Vaccines in Toddlers: a Phase III randomized study

Epidemiology and Infection ◽

10.1017/s0950268821000698 ◽

2021 ◽

pp. 1-39

Author(s):

M. S. Dhingra ◽

L. Namazova-Baranova ◽

J. L. Arredondo-Garcia ◽

K.-H. Kim ◽

K. Limkittikul ◽

...

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Randomized Study ◽

Phase Iii

Download Full-text

SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

ACS Chemical Biology ◽

10.1021/acschembio.1c00272 ◽

2021 ◽

Author(s):

Yury Valdes-Balbin ◽

Darielys Santana-Mederos ◽

Lauren Quintero ◽

Sonsire Fernández ◽

Laura Rodriguez ◽

...

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Preclinical Studies

Download Full-text

Antibody Response to the Haemophilus influenzae Type b–Tetanus Toxoid Conjugate Vaccine in Healthy and Infection-Prone Individuals with IgG3 Subclass Deficiency

Journal of Clinical Immunology ◽

10.1023/b:joci.0000040927.15641.0c ◽

2004 ◽

Vol 24 (5) ◽

pp. 561-570 ◽

Cited By ~ 3

Author(s):

M. Hahn-Zoric ◽

M. Ulanova ◽

V. Friman ◽

J. Björkander ◽

V. A. Oxelius ◽

...

Keyword(s):

Antibody Response ◽

Haemophilus Influenzae ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B ◽

Subclass Deficiency ◽

Igg3 Subclass

Download Full-text

Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine: A Meta-Analysis of Immunogenicity, Safety and Posology

Human Vaccines ◽

10.4161/hv.1.4.2018 ◽

2005 ◽

Vol 1 (4) ◽

pp. 131-139 ◽

Cited By ~ 15

Author(s):

Eva Maria Pöllabauer ◽

Robert Petermann ◽

Hartmut J. Ehrlich

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Meta Analysis

Download Full-text

IMMEDIATE AND LONGER TERM IMMUNOGENICITY OF A SINGLE DOSE OF THE COMBINED HAEMOPHILUS INFLUENZAE TYPE B-NEISSERIA MENINGITIDIS SEROGROUP C-TETANUS TOXOID CONJUGATE VACCINE IN PRIMED TODDLERS 12 TO 18 MONTHS OF AGE

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0b013e31820013d2 ◽

2011 ◽

Vol 30 (4) ◽

pp. 340-342 ◽

Cited By ~ 12

Author(s):

Robert Booy ◽

Peter Richmond ◽

Terry Nolan ◽

Jodie McVernon ◽

Helen Marshall ◽

...

Keyword(s):

Single Dose ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B

Download Full-text

Seroefficacy of Vi Polysaccharide–Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV)

Clinical Infectious Diseases ◽

10.1093/cid/cix1145 ◽

2018 ◽

Vol 67 (1) ◽

pp. 18-24 ◽

Cited By ~ 27

Author(s):

Merryn Voysey ◽

Andrew J Pollard

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid

Download Full-text

T-cell–mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2017.09.076 ◽

2018 ◽

Vol 78 (6) ◽

pp. 1149-1155.e1 ◽

Cited By ~ 15

Author(s):

Kevin L. Winthrop ◽

Neil Korman ◽

William Abramovits ◽

Scott T. Rottinghaus ◽

Huaming Tan ◽

...

Keyword(s):

Immune Response ◽

T Cell ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Pneumococcal Conjugate Vaccine ◽

Severe Psoriasis ◽

Cell Mediated Immune Response

Download Full-text

Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents

Journal of Adolescent Health ◽

10.1016/j.jadohealth.2018.05.012 ◽

2018 ◽

Vol 63 (3) ◽

pp. 269-279 ◽

Cited By ~ 6

Author(s):

Lidia C. Serra ◽

Laura J. York ◽

Paul Balmer ◽

Chris Webber

Keyword(s):

Conjugate Vaccine ◽

Clinical Data ◽

Tetanus Toxoid ◽

Meningococcal Group ◽

Group A

Download Full-text

The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2012.04.006 ◽

2012 ◽

Vol 16 (8) ◽

pp. e608-e615 ◽

Cited By ~ 17

Author(s):

Ghassan Dbaibo ◽

Marie Van der Wielen ◽

Mariam Reda ◽

Fouad Medlej ◽

Carelle Tabet ◽

...

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Safety Profile ◽

Polysaccharide Vaccine ◽

Acceptable Safety Profile

Download Full-text

Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0000000000000897 ◽

2015 ◽

Vol 34 (12) ◽

pp. e298-e307 ◽

Cited By ~ 14

Author(s):

Timo Vesikari ◽

Aino Forsten ◽

Veronique Bianco ◽

Marie Van der Wielen ◽

Jacqueline M. Miller

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Booster Dose ◽

Primary Vaccination ◽

Antibody Persistence

Download Full-text